Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsThe influence of subclonal resistance mutations on targeted cancer therapyNext-generation sequencing: hype and hope for development of personalized radiation therapy?Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung CancerCell-free DNA as a diagnostic marker for cancer: current insightsCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?DNA Sequence Analysis in Clinical Medicine, Proceeding Cautiously.Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerCirculating Cell-Free Tumour DNA in the Management of Cancer.Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in BrazilSerial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug AdministrationTargeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.Ovarian cancer treatment: The end of empiricism?Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire PlatformsQuantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.Circulating tumor DNA detection in lung cancer patients before and after surgeryLiquid Biopsies for Cancer: Coming to a Patient near You.Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.Saliva Liquid Biopsy for Point-of-Care Applications.Cancer diagnostics: The journey from histomorphology to molecular profiling.Circulating biomarkers for gliomas.Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics.Non-Coding RNAs in Thyroid Cancer.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Catalog of genetic progression of human cancers: breast cancer.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.Pathologists and liquid biopsies: to be or not to be?Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.Liquid Biopsy in Non-Small Cell Lung Cancer.
P2860
Q26746010-793401C1-DD1E-4A6D-B960-BF7B571D4759Q26776394-F3085C4F-62AF-4B30-823E-F454ADAC01C1Q26781693-958B0450-A380-4D44-87E3-484236DADBE2Q26796485-34941EB4-1262-4743-870F-949D909768B0Q28067582-17474BED-D90C-40D6-AB78-5B2FB49A9E60Q28074556-6203E915-86C2-43AB-A4E3-BDE0473AA39EQ28077340-17129E58-4DDA-45BA-BCFE-7572BCD0AC66Q33627712-83CE337D-B844-4C31-80DC-46BE963723D5Q33637346-8B3B9A0A-120F-4DCC-BA9D-BA2EA06B360BQ34550417-208323F5-070F-4615-BBE4-8914E4D11C41Q35615320-19F8410C-DCBD-4AB3-A333-FB22A6535725Q35814162-8465EED1-2068-4F8A-B35E-18068A56E59BQ35916109-D4C440C0-30C3-4E65-B5D3-7821CDD4B33CQ36087929-584CF9C9-88BF-4C04-A5F2-2DCC1B4DE3D7Q36132165-8F84EF89-8FBA-4CC3-984A-76D97BD5ECCEQ36242936-400FCC7B-EEC1-4B7B-8E1A-C0B74A8C29DDQ36376138-45E1350D-FE8A-4398-90F4-159DC6C5D593Q36554444-C97C33BF-74CD-42B5-9D8B-52458D028808Q36882961-61B61005-D588-4B93-8E95-D9C34CA8D7BEQ37110941-460092B7-CD31-4742-AFA3-8FE2815785A6Q37264643-F3597D01-0115-4B89-943D-17E1E0ED5038Q37628173-6601C986-86B7-4A9B-BD63-4A596B0A1A12Q37687034-4DEC9AD3-45BE-4585-8877-CEA306F28C59Q37687088-58B423E0-A25B-43B2-AFA3-DF2FFB184E47Q37709234-00FD3175-2A0D-4197-AE26-4708DC6776ECQ37747010-BE153BD7-A0B2-4C62-A7BC-A9DDA1A5E225Q38559476-3199E068-0C4E-488E-B63B-877A806639DEQ38586617-6DD284FF-8B07-4093-89E3-60E1B582E634Q38633504-B92F2BF0-8470-4319-8CBB-582DE8332D2AQ38640437-DA29A7EF-775B-4458-ACC9-C8722B5B3D10Q38723755-9BD7B384-97F9-449F-A852-F9246EFF903EQ38726457-478CBC7B-BC0D-4988-8C00-57ADD6276E27Q38764251-24FF2ADF-82E0-44E9-BD97-3BB8432B8AD7Q38770935-9B15649E-0936-47F2-993C-2FC92439FEF5Q38824891-7CEE73C3-39F4-4942-B050-5D76D92E30EBQ38920745-107B2AA7-122D-498D-A33A-64A8BF658A0DQ38922208-CB563AA2-86E1-464C-9AA1-B768F4FF1D3AQ38935060-4251C246-9702-4359-83F9-C0DA3A026A5FQ39051797-5E510ADE-3552-4E95-9887-C667206ABE17Q39076207-6E1BB19B-6F04-4B8D-8868-665DC787F6EA
P2860
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating tumor DNA as a non ...... trial across all tumor types.
@ast
Circulating tumor DNA as a non ...... trial across all tumor types.
@en
Circulating tumor DNA as a non ...... trial across all tumor types.
@nl
type
label
Circulating tumor DNA as a non ...... trial across all tumor types.
@ast
Circulating tumor DNA as a non ...... trial across all tumor types.
@en
Circulating tumor DNA as a non ...... trial across all tumor types.
@nl
prefLabel
Circulating tumor DNA as a non ...... trial across all tumor types.
@ast
Circulating tumor DNA as a non ...... trial across all tumor types.
@en
Circulating tumor DNA as a non ...... trial across all tumor types.
@nl
P2093
P2860
P50
P1433
P1476
Circulating tumor DNA as a non ...... trial across all tumor types.
@en
P2093
Adrien Saliou
Anthony Blin
Charles Decraene
Céline Callens
Etienne Rouleau
Gaëlle Pierron
Jean-Yves Pierga
Jordan Madic
Maud Kamal
Quentin Leroy
P2860
P304
P356
10.1016/J.MOLONC.2014.12.003
P577
2014-12-26T00:00:00Z